{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:16:30Z","timestamp":1792826190477,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jclinane.2024.111509","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T16:52:28Z","timestamp":1718470348000},"page":"111509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A pharmacovigilance study of FDA adverse events for sugammadex"],"prefix":"10.1016","volume":"97","author":[{"given":"Xiaoyan","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganglan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00540-011-1209-1","article-title":"Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery","volume":"25","author":"Adamus","year":"2011","journal-title":"J Anesth"},{"issue":"1","key":"10.1016\/j.jclinane.2024.111509_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists Practice Guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade","volume":"138","author":"Thilen","year":"2023","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.jclinane.2024.111509_bb0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/bja\/aex116","article-title":"Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis","volume":"118","author":"Bruintjes","year":"2017","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.jclinane.2024.111509_bb0020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1213\/ANE.0000000000005363","article-title":"REsidual neuromuscular block prediction score versus train-of-four ratio and respiratory outcomes: a retrospective cohort study","volume":"133","author":"Patroc\u00ednio","year":"2021","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0025","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1213\/ANE.0000000000005080","article-title":"Utilization patterns of perioperative neuromuscular blockade reversal in the United States: a retrospective observational study from the multicenter perioperative outcomes group","volume":"131","author":"Dubovoy","year":"2020","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.jclinane.2024.111509_bb0030","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","article-title":"Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis","volume":"132","author":"Kheterpal","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jclinane.2024.111509_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jclinane.2017.03.004","article-title":"Role of sugammadex in accelerating postoperative discharge: a meta-analysis","volume":"39","author":"Carron","year":"2017","journal-title":"J Clin Anesth"},{"issue":"10","key":"10.1016\/j.jclinane.2024.111509_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14740338.2019.1649393","article-title":"Safety of sugammadex for reversal of neuromuscular block","volume":"18","author":"Honing","year":"2019","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.jclinane.2024.111509_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","article-title":"Peri-operative management of neuromuscular blockade: a guideline from the European Society of Anaesthesiology and Intensive Care","volume":"40","author":"Fuchs-Buder","year":"2023","journal-title":"Eur J Anaesthesiol"},{"issue":"8","key":"10.1016\/j.jclinane.2024.111509_bb0050","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/anae.14897","article-title":"Reversal of neuromuscular blockade with sugammadex during continuous administration of anaesthetic agents: a double-blind randomised crossover study using the bispectral index","volume":"75","author":"Le Guen","year":"2020","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.jclinane.2024.111509_bb0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4097\/kja.22335","article-title":"Cardiac arrest due to coronary vasospasm after sugammadex administration -a case report","volume":"76","author":"Boo","year":"2023","journal-title":"Korean J Anesthesiol"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","article-title":"Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: recommendations for limiting false-positive associations","volume":"43","author":"Caster","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.jclinane.2024.111509_bb0070","series-title":"Practical aspects of signal detection in pharmacovigilance: Report of CIOMS Working Group VIII: Practical aspects of signal detection in pharmacovigilance: Report of CIOMS Working Group VIII","year":"2010"},{"issue":"10","key":"10.1016\/j.jclinane.2024.111509_bb0075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0895-4356(92)90158-J","article-title":"Serum sickness-like reactions to cefaclor","volume":"45","author":"Stricker","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinane.2024.111509_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101535","article-title":"Toxicity spectrum of immunotherapy in advanced lung cancer: a safety analysis from clinical trials and a pharmacovigilance system","volume":"50","author":"Yan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jclinane.2024.111509_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101967","article-title":"Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database","volume":"59","author":"Zhou","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.jclinane.2024.111509_bb0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s40425-019-0754-2","article-title":"Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system","volume":"7","author":"Zhai","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jclinane.2024.111509_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jad.2023.11.076","article-title":"Mining and analysis of adverse event signals of Cariprazine based on the real-world data of FAERS database","volume":"347","author":"Zhu","year":"2024","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.jclinane.2024.111509_bb0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.jclinane.2024.111509_bb0105","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/cns.14195","article-title":"Updated insights on dementia-related risk of sacubitril\/valsartan: a real-world pharmacovigilance analysis","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"10.1016\/j.jclinane.2024.111509_bb0110","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1515\/cclm-2016-0010","article-title":"Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management","volume":"54","author":"Kounis","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.jclinane.2024.111509_bb0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0310057X211039859","article-title":"The use of sugammadex in critical events in anaesthesia: a retrospective review of the webAIRS database","volume":"50","author":"Olesnicky","year":"2022","journal-title":"Anaesth Intensive Care"},{"issue":"11","key":"10.1016\/j.jclinane.2024.111509_bb0120","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/anae.12736","article-title":"Hypersensitivity associated with sugammadex administration: a systematic review","volume":"69","author":"Tsur","year":"2014","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0125","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1213\/ANE.0000000000002562","article-title":"Incidence of anaphylaxis associated with sugammadex","volume":"126","author":"Miyazaki","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jclinane.2024.111509_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinane.2017.11.003","article-title":"Cardiac arrest following anaphylaxis induced by sugammadex in a regional hospital","volume":"44","author":"Obara","year":"2018","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jclinane.2024.111509_bb0140","article-title":"Two cardiac arrests that occurred after the administration of sugammadex: a case of kounis syndrome","volume":"2020","author":"Yanai","year":"2020","journal-title":"Case Rep Emerg Med"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/0310057X231173001","article-title":"Complete heart block of multifactorial aetiology following sugammadex administration","volume":"51","author":"Jeyadoss","year":"2023","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"10.1016\/j.jclinane.2024.111509_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bcp.15417","article-title":"Safety of sugammadex for reversal of neuromuscular block: a postmarketing study based on the World Health Organization pharmacovigilance database","volume":"89","author":"Lyu","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0155","article-title":"A case report of acute onset and rapid resolution of atrioventricular block after sugammadex: is the autonomic system involved?","volume":"17","author":"Abdelrahim","year":"2023","journal-title":"A A Pract"},{"issue":"1","key":"10.1016\/j.jclinane.2024.111509_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bja.2023.10.032","article-title":"The effect of sugammadex on patient morbidity and quality of recovery after general anaesthesia: a systematic review and meta-analysis","volume":"132","author":"Olesnicky","year":"2024","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.jclinane.2024.111509_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bja.2023.10.002","article-title":"Reversal of neuromuscular block by sugammadex is associated with less postoperative respiratory dysfunction in the PACU compared with neostigmine: a retrospective study","volume":"132","author":"Lee","year":"2024","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.jclinane.2024.111509_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132367","article-title":"Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo","volume":"10","author":"Ashina","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.jclinane.2024.111509_bb0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.13816","article-title":"Sugammadex and laryngospasm","volume":"72","author":"Greenaway","year":"2017","journal-title":"Anaesthesia"},{"issue":"52","key":"10.1016\/j.jclinane.2024.111509_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018406","article-title":"Comparison of recovery profiles in patients with Parkinson\u2019s disease for 2 types of neuromuscular blockade reversal agent following deep brain stimulator implantation","volume":"98","author":"Park","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jclinane.2024.111509_bb0190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s12028-019-00901-6","article-title":"Sugammadex administration to facilitate timely neurologic examination in the traumatic brain injury patient","volume":"32","author":"Curley","year":"2020","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.jclinane.2024.111509_bb0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/anae.14160","article-title":"The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis","volume":"73","author":"Hristovska","year":"2018","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.jclinane.2024.111509_bb0200","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.bja.2022.04.023","article-title":"Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study","volume":"130","author":"Colquhoun","year":"2023","journal-title":"Br J Anaesth"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818024001387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818024001387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T21:12:57Z","timestamp":1726089177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818024001387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":38,"alternative-id":["S0952818024001387"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2024.111509","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pharmacovigilance study of FDA adverse events for sugammadex","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2024.111509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111509"}}